Annual Total Expenses
$170.28 M
+$42.84 M+33.62%
31 December 2023
Summary:
ALX Oncology Holdings annual total expenses is currently $170.28 million, with the most recent change of +$42.84 million (+33.62%) on 31 December 2023. During the last 3 years, it has risen by +$86.72 million (+103.79%). ALXO annual total expenses is now at all-time high.ALXO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$32.57 M
-$8.96 M-21.57%
30 September 2024
Summary:
ALX Oncology Holdings quarterly total expenses is currently $32.57 million, with the most recent change of -$8.96 million (-21.57%) on 30 September 2024. Over the past year, it has dropped by -$15.46 million (-32.18%). ALXO quarterly total expenses is now -38.87% below its all-time high of $53.27 million, reached on 30 September 2023.ALXO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALXO Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -32.2% |
3 y3 years | +103.8% | +14.4% |
5 y5 years | +610.1% | +264.0% |
ALXO Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +103.8% | -38.9% | +31.6% |
5 y | 5 years | at high | +610.1% | -38.9% | +452.3% |
alltime | all time | at high | +981.1% | -38.9% | +659.1% |
ALX Oncology Holdings Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $32.57 M(-21.6%) |
June 2024 | - | $41.52 M(+10.0%) |
Mar 2024 | - | $37.76 M(-21.4%) |
Dec 2023 | $170.28 M(+33.6%) | $48.02 M(-9.9%) |
Sept 2023 | - | $53.27 M(+44.9%) |
June 2023 | - | $36.78 M(+14.2%) |
Mar 2023 | - | $32.20 M(-0.0%) |
Dec 2022 | $127.44 M(+52.5%) | $32.22 M(-12.2%) |
Sept 2022 | - | $36.68 M(+8.6%) |
June 2022 | - | $33.79 M(+36.5%) |
Mar 2022 | - | $24.75 M(-13.1%) |
Dec 2021 | $83.56 M | $28.47 M(+15.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $24.58 M(+50.8%) |
June 2021 | - | $16.30 M(+14.7%) |
Mar 2021 | - | $14.21 M(-20.3%) |
Dec 2020 | $44.84 M(+87.0%) | $17.82 M(+81.7%) |
Sept 2020 | - | $9.81 M(-13.3%) |
June 2020 | - | $11.31 M(+91.9%) |
Mar 2020 | - | $5.90 M(-34.1%) |
Dec 2019 | $23.98 M(+52.2%) | $8.95 M(+108.5%) |
Sept 2019 | - | $4.29 M(-21.8%) |
June 2019 | - | $5.48 M(+4.3%) |
Mar 2019 | - | $5.26 M |
Dec 2018 | $15.75 M | - |
FAQ
- What is ALX Oncology Holdings annual total expenses?
- What is the all time high annual total expenses for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly total expenses year-on-year change?
What is ALX Oncology Holdings annual total expenses?
The current annual total expenses of ALXO is $170.28 M
What is the all time high annual total expenses for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual total expenses is $170.28 M
What is ALX Oncology Holdings quarterly total expenses?
The current quarterly total expenses of ALXO is $32.57 M
What is the all time high quarterly total expenses for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly total expenses is $53.27 M
What is ALX Oncology Holdings quarterly total expenses year-on-year change?
Over the past year, ALXO quarterly total expenses has changed by -$15.46 M (-32.18%)